References
- Parke DW, Sisk RA, Murray TG. Intraoperative intravitreal triamcinolone decreases macular edema after vitrectomy with phacoemulsification. Clin Ophthalmol 2012;6:1347–1353
- Parolini B, Sartore M. Incidence of cystoid macular edema after vitrectomy for ERM. Presented at EVRS 2012 Congress; 2012 Sept 15–18; Dresden, Germany
- Kim SJ, Martin DF, Hubbard 3rd GB, et al. Incidence of postvitrectomy macular edema using optical coherence tomography. Ophthalmology 2009;116:1531–1537
- Cho H, Madu A. Etiology and treatment of the inflammatory causes of cystoid macular edema. J Inflamm Res 2009;2:37–43
- Chen TH, Wang JK, Chang SW. Intravitreal dexamethasone implant for a vitrectomised eye with diabetic macular edema. Taiwan J Ophthalmol 2013. Available from: http://www.e-tjo.com/article/S2211-5056%2813%2900029-X/abstract [last accessed Aug 2014]
- Reibaldi M, Russo A, Zagari M, et al. Resolution of persistent cystoid macular edema due to central retinal vein occlusion in a vitrectomized eye following intravitreal implant of dexamethasone 0.7 mg. Case Rep Ophthalmol 2012;3:30–34
- Feiner L. Dexamethasone implant for treatment of DME in vitrectomized patients. Retina Today 2010:62–63
- Adán A, Pelegrín L, Rey A, et al. Dexamethasone intravitreal implant for treatment ofuveitic persistent cystoid macular edema in vitrectomized patients. Retina 2013;33:1435–1440
- Chang-Lin JE, Burke JA, Peng, Q. Pharmacokinetics of a sustained release dexamethasone intravitreal implant in vitrectomized and non vitrectomized eyes. Invest Ophthalmol Vis Sci 2011;52:4605–4609
- Shahsuvaryan ML. Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusion. Int J Ophthalmol 2012;5:759–770
- Robinson ΜR, Whitcup SM. Pharmacologic and clinical profile of dexamethasone intravitreal implant. Expert Rev Clin Pharmacol 2012;5:629–647
- Shaikh AH, Petersen MR, Sisk RA, et al. Comparative effectiveness of the dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to central retinal vein occlusion. Ophthalmic Surg Lasers Imaging Retina 2013;44:28–33
- Malclès A, Janin-Manificat H, Yhuel Y, et al. Anterior chamber migration of intravitreal dexamethasone implant (Ozurdex®) in pseudophakic eyes: report of three cases. J Fr Ophthalmol 2013;36:362–367